Hap Trading, LLC Dexcom Inc Put Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $973,820 - $1.6 Million	12,900 New	12,900 $9.88 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $1.81 Million - $2.11 Million	16,100 New	16,100 $2.07 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $33,992 - $49,068	-400 Reduced 3.33%	11,600 $10,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $61,079 - $75,344	-800 Reduced 6.25%	12,000 $136,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $61,190 - $119,600	900 Added 7.56%	12,800 $197,000
Q3 2021 Nov 10, 2021	SELL	$106.71 - $143.18 $32,012 - $42,954	-300 Reduced 2.46%	11,900 $87,000
Q2 2021 Aug 11, 2021	SELL	$80.99 - $107.93 $5.99 Million - $7.99 Million	-74,000 Reduced 85.85%	12,200 $106,000
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $304,200 - $407,550	3,900 Added 4.74%	86,200 $222,000
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $105,061 - $124,245	1,100 Added 1.35%	82,300 $349,000
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $200,576 - $337,088	3,200 Added 4.1%	81,200 $740,000
Q1 2020 May 08, 2020	SELL	$47.79 - $75.63 $2.44 Million - $3.86 Million	-51,100 Reduced 39.58%	78,000 $2.73 Million
Q4 2019 Feb 11, 2020	BUY	$36.62 - $57.29 $4.73 Million - $7.4 Million	129,100 New	129,100 $635,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.